FDA Week - 02/14/2020

FDA Hopes To Scale Back Genetically Altered Animal Regs

By Kelly Lienhard / February 12, 2020 at 11:49 AM
A senior policy advisor for FDA told Inside Health Policy the agency hopes its newly developed method for collecting and analyzing data on genetic alteration in animals intended for human consumption will allow the agency to eventually scale back its regulation of genetically modified animals. FDA believes the gene alterations space has potential to grow, as there are people interested in using the technology to develop disease resistance in certain animals. “In the future, we will be able to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.